[go: up one dir, main page]

PL345037A1 - Cyclic somatostatin analogs - Google Patents

Cyclic somatostatin analogs

Info

Publication number
PL345037A1
PL345037A1 PL99345037A PL34503799A PL345037A1 PL 345037 A1 PL345037 A1 PL 345037A1 PL 99345037 A PL99345037 A PL 99345037A PL 34503799 A PL34503799 A PL 34503799A PL 345037 A1 PL345037 A1 PL 345037A1
Authority
PL
Poland
Prior art keywords
somatostatin analogs
cyclic somatostatin
cyclic
analogs
somatostatin
Prior art date
Application number
PL99345037A
Inventor
Thomas D Gordon
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of PL345037A1 publication Critical patent/PL345037A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL99345037A 1998-06-16 1999-06-11 Cyclic somatostatin analogs PL345037A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8950398P 1998-06-16 1998-06-16
US9818198A 1998-06-16 1998-06-16
PCT/US1999/013304 WO1999065942A1 (en) 1998-06-16 1999-06-11 Cyclic somatostatin analogs

Publications (1)

Publication Number Publication Date
PL345037A1 true PL345037A1 (en) 2001-11-19

Family

ID=26780645

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99345037A PL345037A1 (en) 1998-06-16 1999-06-11 Cyclic somatostatin analogs

Country Status (12)

Country Link
EP (1) EP1086131A1 (en)
JP (1) JP2002518409A (en)
CN (1) CN1200000C (en)
AR (1) AR021161A1 (en)
AU (1) AU745493B2 (en)
CA (1) CA2335184A1 (en)
HU (1) HUP0102902A3 (en)
NO (1) NO20006320L (en)
PL (1) PL345037A1 (en)
RU (1) RU2242481C2 (en)
TW (3) TW527361B (en)
WO (1) WO1999065942A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523921A (en) 1998-06-12 2003-08-12 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス Imidazolyl derivatives
FR2796945B1 (en) * 1999-07-30 2002-06-28 Sod Conseils Rech Applic NOVEL DERIVATIVES OF HYDANTOINS, THIOHYDANTOINS, PYRIMIDINEDIONES AND THIOXOPYRIMIDINONES, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
AR035040A1 (en) * 2000-08-01 2004-04-14 Sod Conseils Rech Applic IMIDAZOLIL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THEM FOR THE PREPARATION OF MEDICINES ABLE TO SELECTIVELY JOIN SUBTIPOS OF THE SOMATOSTATIN RECEIVER
US20040186151A1 (en) * 2003-02-12 2004-09-23 Mjalli Adnan M.M. Substituted azole derivatives as therapeutic agents
WO2006063465A1 (en) * 2004-12-15 2006-06-22 Diamedica Inc. Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists
ATE511502T1 (en) 2005-12-14 2011-06-15 Bristol Myers Squibb Co ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPINAMIDE OR ARYLMETHYLUREA ANALOGUES AS FACTOR XIA INHIBITORS
CN101341129B (en) * 2005-12-14 2011-12-14 布里斯托尔-迈尔斯斯奎布公司 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
EA201170493A1 (en) 2008-09-26 2011-10-31 Амбркс, Инк. MICROORGANISMS AND VACCINES DEPENDING ON REPLICATION OF NON-NATURAL AMINO ACIDS
EP2168983A1 (en) * 2008-09-30 2010-03-31 Ipsen Pharma New octapeptide compounds and their therapeutic use
WO2010050445A1 (en) 2008-10-27 2010-05-06 武田薬品工業株式会社 Bicyclic compound
IL320126A (en) * 2016-02-09 2025-06-01 Cdrd Ventures Inc Somatostatin receptor antagonist compounds and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
GB9513224D0 (en) * 1995-06-29 1995-09-06 Sandoz Ltd Organic compounds
US6673927B2 (en) * 1996-02-16 2004-01-06 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Farnesyl transferase inhibitors

Also Published As

Publication number Publication date
NO20006320D0 (en) 2000-12-12
EP1086131A1 (en) 2001-03-28
WO1999065942A1 (en) 1999-12-23
AU745493B2 (en) 2002-03-21
NO20006320L (en) 2001-02-12
TW200410986A (en) 2004-07-01
WO1999065942A8 (en) 2000-02-17
AR021161A1 (en) 2002-07-03
RU2242481C2 (en) 2004-12-20
CN1305496A (en) 2001-07-25
TWI242441B (en) 2005-11-01
AU4822399A (en) 2000-01-05
TWI242442B (en) 2005-11-01
JP2002518409A (en) 2002-06-25
TW527361B (en) 2003-04-11
CN1200000C (en) 2005-05-04
HUP0102902A2 (en) 2002-01-28
CA2335184A1 (en) 1999-12-23
HUP0102902A3 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
SI1307486T1 (en) Somatostatin analogues
CZ20011342A3 (en) Cyclic tetrapeptides
CZ20012876A3 (en) SP-C analogs
IL139885A0 (en) Cyclic boroproline compounds
HUP0202812A3 (en) Novel bicyclonucleoside analogues
GB9926183D0 (en) LED components
ZA9830B (en) Cyclic sulfone derivatives
AU4114201A (en) Cyclic compounds
DE69941708D1 (en) PACAP PEPTIDE ANALOGS
EP0996458A4 (en) SANDRAMYCIN ANALOGS
AU4524401A (en) Receptor-selective somatostatin analogs
EG23909A (en) Vatamin d, analogs
PL348763A1 (en) Phenyl-substituted cyclic enaminones
IL141276A0 (en) Backbone cyclized radiolabelled somatostatin analogs
PL345037A1 (en) Cyclic somatostatin analogs
IL139218A0 (en) 2-aroyl-4-acyl-paclitaxel (taxol) analogs
ZA985896B (en) Cyclic azapeptides
EP1233774A4 (en) Urotensin-ii analogs
GB9823835D0 (en) Component for vaccine
AU1126300A (en) Hydrophilic somatostatin analogs
GB9929433D0 (en) Cyclic compound
AU6382999A (en) Somatostatin analogs
TW329729U (en) Cyclic tool
GB9828612D0 (en) Sequence
GB9823638D0 (en) Sequence

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)